
New medication to treat monkeypox is to be trialled by a team that leads on breakthrough Covid treatments.
The drug, which could help speed up recovery for those infected by monkeypox, is being trialled by a team of scientists at Oxford University after it received £3.7m from the National Institute for Health and Care Research (NIHR).